These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 475360)

  • 1. Characteristics of herpesvirus mutants resistant to phosphonoformate and phosphonoacetate.
    Eriksson B; Oberg B
    Antimicrob Agents Chemother; 1979 Jun; 15(6):758-62. PubMed ID: 475360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.
    Johnson JC; Attanasio R
    Intervirology; 1987; 28(2):89-99. PubMed ID: 2965115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of herpes simplex virus resistance to disodium phosphonoacetate.
    Duff RG; Robishaw EE; Mao JC; Overby LR
    Intervirology; 1978; 9(4):193-205. PubMed ID: 201588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of herpesvirus multiplication in guinea pig skin by antiviral compounds.
    Alenius S
    Arch Virol; 1980; 65(2):149-56. PubMed ID: 6252867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibilities of phosphonoacetic acid and acyclovir resistant varicella-zoster virus mutants to 9-beta-arabinofuranosyladenine and 1-beta-arabinofuranosylcytosine.
    Shiraki K; Ogino T; Yamamoto T; Yamanishi K; Takahashi M
    Biken J; 1986 Mar; 29(1):11-7. PubMed ID: 3022709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2.
    Ayisi NK; Gupta VS; Meldrum JB; Taneja AK; Babiuk LA
    Antimicrob Agents Chemother; 1980 Apr; 17(4):558-66. PubMed ID: 6249191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus DNA polymerase as the site of phosphonoacetate sensitivity: temperature-sensitive mutants.
    Purifoy DJ; Powell KL
    J Virol; 1977 Nov; 24(2):470-7. PubMed ID: 199734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiherpesvirus action of phosphonoacetate.
    Boezi JA
    Pharmacol Ther; 1979; 4(1):231-43. PubMed ID: 88744
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered biological and biochemical properties of a phosphonoacetate-resistant mutant of herpesvirus of turkeys.
    Lee LF; Nazerian K; Witter RL; Leinbach SS; Boezi JA
    IARC Sci Publ (1971); 1978; (24 Pt 1):253-60. PubMed ID: 221331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral potential of phosphonoacetic acid.
    Overby LR; Duff RG; Mao JC
    Ann N Y Acad Sci; 1977 Mar; 284():310-20. PubMed ID: 212978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.
    Honess RW; Watson DH
    J Virol; 1977 Feb; 21(2):584-600. PubMed ID: 189089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the DNA polymerases induced by a group of herpes simplex virus type I variants selected for growth in the presence of phosphonoformic acid.
    Derse D; Bastow KF; Cheng Y
    J Biol Chem; 1982 Sep; 257(17):10251-60. PubMed ID: 6286645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate.
    Reno JM; Lee LF; Boezi JA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):188-92. PubMed ID: 206200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphonoformate inhibits reverse transcriptase.
    Sundquist B; Oberg B
    J Gen Virol; 1979 Nov; 45(2):273-81. PubMed ID: 94344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of phosphonoacetic acid and phosphonoformic acid activity in genital herpes simplex virus type 1 and type 2 infections of mice.
    Kern ER; Richards JT; Overall JC; Glasgow LA
    Antiviral Res; 1981 Nov; 1(4):225-35. PubMed ID: 6280607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of trisodium phosphonoformate and idoxuridine on experimental herpes simplex keratitis in immunized and non-immunized rabbits.
    Alenius S; Laurent U; Oberg B
    Acta Ophthalmol (Copenh); 1980 Apr; 58(2):167-73. PubMed ID: 6249066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phosphonoacetate-resistant mutant of herpesvirus of turkeys.
    Lee LF; Nazerian K; Witter RL; Leinbach SS; Boezi JA
    J Natl Cancer Inst; 1978 May; 60(5):1141-6. PubMed ID: 76681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.